Inactive Instrument

Insiders Herantis Pharma Oyj Nasdaq Helsinki

Equities

FI4000087861

Insiders

Unlock all the news: Be the first to know and act before the market!

Proposals of the Shareholders' Nomination Committee to Herantis Pharma Plc's Annual General Meeting 2023	20/23/20	AQ
Composition of Herantis Pharma Plc's Shareholders' Nomination Committee	26/22/26	AQ
Herantis Pharma plc Announces Appointments to Shareholders' Nomination Committee	26/22/26	CI
Antti Vuolanto appointed as CEO of Herantis as of 22 July 2022	08/22/08	AQ
Herantis Pharma plc Announces Executive Changes	08/22/08	CI
Proposals of the Shareholders' Nomination Committee to Herantis Pharma Plc's Annual General Meeting 2022	14/22/14	AQ
Herantis Pharma Oyj Announces CEO Changes	20/22/20	CI
Composition of Herantis Pharma Plc's Shareholders' Nomination Committee	15/21/15	AQ
Herantis Pharma Plc Announces Executive Appointments	15/21/15	CI
Herantis Pharma plc Announces Members of Scientific Advisory Board	25/21/25	CI
Herantis Pharma Oyj : Names Chairman of New Scientific Advisory Board	14/21/14	MT
Herantis Pharma Announces Formation of New Scientific Advisory Board with Dr. Anders Gersel Pedersen as Chairman	14/21/14	CI
Herantis Pharma Oyj Announces Board Committee Appointments	26/21/26	CI
Herantis Pharma Plc Elects Hilde Furberg to its Board of Directors	15/21/15	CI
Herantis Pharma Oyj : Composition of Herantis Pharma Plc's Shareholders' Nomination Committee	01/21/01	AQ
Herantis Pharma Oyj Announces Nomination Committee Appointments	01/21/01	CI
Herantis Pharma plc Appoints Magnus Sjögren as Chief Medical Officer, Effective May 1, 2021	22/21/22	CI
Ingrid Heiman to Leave Herantis Pharma's Board of Directors	30/20/30	CI
Herantis Pharma Plc Appoints Tone Kvåle as Chief Financial Officer	26/20/26	CI
Herantis Pharma Plc Appoints Tone Kvåle as Member of the Management Team	26/20/26	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Herantis Pharma Oyj Nasdaq Helsinki

Equities

FI4000087861

Insiders

Filters